Neural effects of methylphenidate and nicotine during smooth pursuit eye movements

[1]  Edmund T. Rolls,et al.  Implementation of a new parcellation of the orbitofrontal cortex in the automated anatomical labeling atlas , 2015, NeuroImage.

[2]  G. Fond,et al.  Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review , 2015, Psychiatry Research.

[3]  L. Whetstine.  Cognitive Enhancement: Treating or Cheating? , 2015, Seminars in pediatric neurology.

[4]  E. Seifritz,et al.  Pharmacological Cognitive Enhancement in Healthy Individuals: A Compensation for Cognitive Deficits or a Question of Personality? , 2015, PloS one.

[5]  B. Weber,et al.  Neural mechanisms of smooth pursuit eye movements in schizotypy , 2015, Human brain mapping.

[6]  Bernd Weber,et al.  Functional magnetic resonance imaging of sensorimotor transformations in saccades and antisaccades , 2014, NeuroImage.

[7]  H. Möller,et al.  The effects of methylphenidate on whole brain intrinsic functional connectivity , 2014, Human brain mapping.

[8]  Marko Wilke,et al.  Isolated Assessment of Translation or Rotation Severely Underestimates the Effects of Subject Motion in fMRI Data , 2014, PloS one.

[9]  Elliot A. Stein,et al.  Dual role of nicotine in addiction and cognition: A review of neuroimaging studies in humans , 2014, Neuropharmacology.

[10]  R. Poldrack.  Is “efficiency” a useful concept in cognitive neuroscience? , 2014, Developmental Cognitive Neuroscience.

[11]  E. Vuurman,et al.  Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies. , 2014, The international journal of neuropsychopharmacology.

[12]  A. Waters,et al.  Subjective, Physiological, and Cognitive Responses to Intravenous Nicotine: Effects of Sex and Menstrual Cycle Phase , 2014, Neuropsychopharmacology.

[13]  M. Bellgrove,et al.  Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks , 2014, Neuropsychologia.

[14]  E. Yechiam,et al.  Methylphenidate Enhances Cognitive Performance in Adults With Poor Baseline Capacities Regardless of Attention-Deficit/Hyperactivity Disorder Diagnosis , 2014, Journal of clinical psychopharmacology.

[15]  Shenmin Zhang,et al.  The effects of methylphenidate on cerebral activations to salient stimuli in healthy adults. , 2014, Experimental and clinical psychopharmacology.

[16]  Michael Angstadt,et al.  Distributed effects of methylphenidate on the network structure of the resting brain: A connectomic pattern classification analysis , 2013, NeuroImage.

[17]  W. Maier,et al.  Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls. , 2013, The international journal of neuropsychopharmacology.

[18]  H. Möller,et al.  Methylphenidate effects on neural activity during response inhibition in healthy humans. , 2013, Cerebral cortex.

[19]  E. Evers,et al.  Methylphenidate reduces functional connectivity of nucleus accumbens in brain reward circuit , 2013, Psychopharmacology.

[20]  Imre Bard,et al.  What should we do about student use of cognitive enhancers? An analysis of current evidence , 2013, Neuropharmacology.

[21]  Jason R. Tregellas,et al.  Nicotine increases brain functional network efficiency , 2012, NeuroImage.

[22]  Steven C. R. Williams,et al.  Methylphenidate Effects on Prefrontal Functioning During Attentional-Capture and Response Inhibition , 2012, Biological Psychiatry.

[23]  F. Binkofski,et al.  Altered Velocity Processing in Schizophrenia during Pursuit Eye Tracking , 2012, PloS one.

[24]  U. Ettinger,et al.  Effects of methylphenidate on basic and higher-order oculomotor functions , 2012, Journal of psychopharmacology.

[25]  Michael Wagner,et al.  Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy , 2012, Psychopharmacology.

[26]  Marko Wilke,et al.  An alternative approach towards assessing and accounting for individual motion in fMRI timeseries , 2012, NeuroImage.

[27]  Simon C. Potter,et al.  A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans , 2012, PLoS ONE.

[28]  W. Maier,et al.  Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy , 2011, Psychopharmacology.

[29]  C. Thiel,et al.  Functional brain imaging of nicotinic effects on higher cognitive processes. , 2011, Biochemical pharmacology.

[30]  T. Wallace,et al.  Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. , 2011, Biochemical pharmacology.

[31]  G. Dawson,et al.  Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy , 2011, Psychopharmacology.

[32]  P. Liddle,et al.  Task-related default mode network modulation and inhibitory control in ADHD: effects of motivation and methylphenidate. , 2011, Journal of child psychology and psychiatry, and allied disciplines.

[33]  M. D’Esposito,et al.  Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control , 2011, Biological Psychiatry.

[34]  Mark Slifstein,et al.  Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. , 2011, The American journal of psychiatry.

[35]  S. Hyman,et al.  Cognitive Enhancement: Promises and Perils , 2011, Neuron.

[36]  Steven C. R. Williams,et al.  Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers , 2011, Neuropsychopharmacology.

[37]  Nora D. Volkow,et al.  Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls , 2011, NeuroImage.

[38]  M. Husain,et al.  Cognitive enhancement by drugs in health and disease , 2011, Trends in Cognitive Sciences.

[39]  Volkmar Glauche,et al.  Visual motion, eye motion, and relative motion: A parametric fMRI study of functional specializations of smooth pursuit eye movement network areas. , 2010, Journal of vision.

[40]  Richard E. Carson,et al.  Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo , 2010, Biological Psychiatry.

[41]  S. Heishman,et al.  Meta-analysis of the acute effects of nicotine and smoking on human performance , 2010, Psychopharmacology.

[42]  Tom Manly,et al.  Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study , 2010, Psychopharmacology.

[43]  C. Kieling,et al.  A current update on ADHD pharmacogenomics. , 2010, Pharmacogenomics.

[44]  Thomas Stephan,et al.  Functional Magnetic Resonance Imaging Activations of Cortical Eye Fields during Saccades, Smooth Pursuit, and Optokinetic Nystagmus , 2009, Annals of the New York Academy of Sciences.

[45]  Steven C. R. Williams,et al.  Effects of acute nicotine on brain function in healthy smokers and non-smokers: Estimation of inter-individual response heterogeneity , 2009, NeuroImage.

[46]  Stefan Van der Stigchel,et al.  A review on eye movement studies in childhood and adolescent psychiatry , 2008, Brain and Cognition.

[47]  J. Sweeney,et al.  Pharmacological treatment effects on eye movement control , 2008, Brain and Cognition.

[48]  R. Lencer,et al.  Neurophysiology and neuroanatomy of smooth pursuit in humans , 2008, Brain and Cognition.

[49]  G. Barnes,et al.  Cognitive processes involved in smooth pursuit eye movements , 2008, Brain and Cognition.

[50]  M. Greenlee,et al.  fMRI evidence for sensorimotor transformations in human cortex during smooth pursuit eye movements , 2008, Neuropsychologia.

[51]  T. Robbins,et al.  Methylphenidate Has Differential Effects on Blood Oxygenation Level-Dependent Signal Related to Cognitive Subprocesses of Reversal Learning , 2008, The Journal of Neuroscience.

[52]  Francesca Pistoia,et al.  Cognition enhancers between treating and doping the mind. , 2008, Pharmacological research.

[53]  Canan Karatekin,et al.  Eye tracking studies of normative and atypical development , 2007 .

[54]  Lars Farde,et al.  Measurement of Methylphenidate-Induced Change in Extrastriatal Dopamine Concentration using [11C]FLB 457 PET , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  R. Cools.  Dopaminergic modulation of cognitive function-implications for l-DOPA treatment in Parkinson's disease , 2006, Neuroscience & Biobehavioral Reviews.

[56]  G. R. Fink,et al.  The modulatory effects of nicotine on parietal cortex activity in a cued target detection task depend on cue reliability , 2006, Neuroscience.

[57]  Tom Johnstone,et al.  Motion correction and the use of motion covariates in multiple‐subject fMRI analysis , 2006, Human brain mapping.

[58]  J. Tanabe,et al.  Effects of Nicotine on Hippocampal and Cingulate Activity During Smooth Pursuit Eye Movement in Schizophrenia , 2006, Biological Psychiatry.

[59]  T. Petros,et al.  Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits , 2006, Physiology & Behavior.

[60]  M. Gill,et al.  Association between Dopamine Transporter (DAT1) Genotype, Left-Sided Inattention, and an Enhanced Response to Methylphenidate in Attention-Deficit Hyperactivity Disorder , 2005, Neuropsychopharmacology.

[61]  U. Ilg,et al.  The neural basis of smooth-pursuit eye movements , 2005, Current Opinion in Neurobiology.

[62]  Jennifer J. Pokorny,et al.  Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys , 2005, The European journal of neuroscience.

[63]  Yu-Shin Ding,et al.  Imaging the Effects of Methylphenidate on Brain Dopamine: New Model on Its Therapeutic Actions for Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.

[64]  Karl J. Friston,et al.  Conjunction revisited , 2005, NeuroImage.

[65]  K. Zilles,et al.  Nicotine Modulates Reorienting of Visuospatial Attention and Neural Activity in Human Parietal Cortex , 2005, Neuropsychopharmacology.

[66]  Jesper Andersson,et al.  Valid conjunction inference with the minimum statistic , 2005, NeuroImage.

[67]  J. Tanabe,et al.  FMRI of response to nicotine during a smooth pursuit eye movement task in schizophrenia. , 2005, The American journal of psychiatry.

[68]  T. George,et al.  Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders , 2004, Journal of psychopharmacology.

[69]  L. Bizarro,et al.  Differential effects of psychomotor stimulants on attentional performance in rats: nicotine, amphetamine, caffeine and methylphenidate , 2004, Behavioural pharmacology.

[70]  C. Pierrot-Deseilligny,et al.  Eye movement control by the cerebral cortex , 2004, Current opinion in neurology.

[71]  Joseph A Maldjian,et al.  Precentral gyrus discrepancy in electronic versions of the Talairach atlas , 2004, NeuroImage.

[72]  G. Thaker,et al.  Effects of Nicotine on Leading Saccades during Smooth Pursuit Eye Movements in Smokers and Nonsmokers with Schizophrenia , 2003, Neuropsychopharmacology.

[73]  Veena Kumari,et al.  Cognitive effects of nicotine in humans: an fMRI study , 2003, NeuroImage.

[74]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[75]  B. Hahn,et al.  Involvement of the prefrontal cortex but not the dorsal hippocampus in the attention-enhancing effects of nicotine in rats , 2003, Psychopharmacology.

[76]  S. Lal,et al.  Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study , 2002, Neuropsychopharmacology.

[77]  Teresa A Blaxton,et al.  The effects of nicotine on specific eye tracking measures in schizophrenia , 2002, Biological Psychiatry.

[78]  J. Swanson,et al.  Pharmacokinetic and pharmacodynamic properties of stimulants: implications for the design of new treatments for ADHD , 2002, Behavioural Brain Research.

[79]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[80]  E. Levin,et al.  Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. , 2001, Experimental and clinical psychopharmacology.

[81]  Yu-Shin Ding,et al.  Therapeutic Doses of Oral Methylphenidate Significantly Increase Extracellular Dopamine in the Human Brain , 2001, The Journal of Neuroscience.

[82]  P. Newhouse,et al.  The effects of nicotine on Parkinson's disease. , 2000, Brain and cognition.

[83]  T. Isa,et al.  Injection of nicotine into the superior colliculus facilitates occurrence of express saccades in monkeys. , 1999, Journal of neurophysiology.

[84]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[85]  M. Corbetta,et al.  A Common Network of Functional Areas for Attention and Eye Movements , 1998, Neuron.

[86]  R. Freedman,et al.  Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients , 1998, Neuropsychopharmacology.

[87]  L. Ni,et al.  Effects of tobacco smoking on human ocular smooth pursuit , 1997, Clinical pharmacology and therapeutics.

[88]  J S Fowler,et al.  Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. , 1995, Archives of general psychiatry.

[89]  Jean Logan,et al.  Imaging endogenous dopamine competition with [11C]raclopride in the human brain , 1994, Synapse.

[90]  A. Lahti,et al.  Tobacco smoking increases square-wave jerks during pursuit eye movements , 1991, Biological Psychiatry.

[91]  R. T. Pivik,et al.  The effects of background illumination and stimulant medication on smooth pursuit eye movements of hyperactive children , 1989, Journal of abnormal child psychology.

[92]  K. Manning,et al.  The effects of tobacco smoking on smooth pursuit eye movements , 1988, Annals of neurology.

[93]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[94]  C. Nilsson,et al.  Frontiers of Biomolecular Exploration in Brain Disorders , 2014, Neuropsychopharmacology.

[95]  Nao Ninomiya,et al.  The 10th anniversary of journal of visualization , 2007, J. Vis..

[96]  H. S. Koelega.  Stimulant drugs and vigilance performance: a review , 2005, Psychopharmacology.

[97]  J. Lynch,et al.  Input to the primate frontal eye field from the substantia nigra, superior colliculus, and dentate nucleus demonstrated by transneuronal transport , 2004, Experimental Brain Research.

[98]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .